← Back to headlines
Marinomed to File for Insolvency Proceedings Due to Unpaid Debts
Austrian biotech company Marinomed announced its intention to file for insolvency proceedings without self-administration, citing the inability to implement its restructuring plan due to missing payments from Unither for the sale of its Carragelose business.
Sources
Showing 0 of 1 sources
No articles available in your preferred languages.
1 article available in other languages below.
